Novel compounds that find use as imaging agents within nuclear medicine applications (PET imaging) for imaging of cardiac innervation are disclosed. These PET based radiotracers may exhibit increased stability, decreased NE release (thereby reducing side effects), improved quantitative data, and/or
Novel compounds that find use as imaging agents within nuclear medicine applications (PET imaging) for imaging of cardiac innervation are disclosed. These PET based radiotracers may exhibit increased stability, decreased NE release (thereby reducing side effects), improved quantitative data, and/or high affinity for VMAT over prior radiotracers. Methods of using the compounds to image cardiac innervation are also provided. In some instances the compounds are developed by derivatizing certain compounds with 18F in a variety of positions: aryl, alkyl, a keto, benzylic, beta-alkylethers, gamma-propylalkylethers and beta-proplylalkylethers. Alternatively or additionally, a methyl group a is added to the amine, and/or the catechol functionality is either eliminated or masked as a way of making these compounds more stable.
대표청구항▼
1. A compound of the structure: or a salt thereof, wherein n is 0;A and R2 are absent;X, W, R and R3 are hydrogen;R1 is NHC(═NH)NH2;Y is H, F, Cl, or Br; andZ is OR4 and R4 is alkyl substituted with 18F. 2. A method of imaging cardiac innervation comprising the steps of: administering an effective a
1. A compound of the structure: or a salt thereof, wherein n is 0;A and R2 are absent;X, W, R and R3 are hydrogen;R1 is NHC(═NH)NH2;Y is H, F, Cl, or Br; andZ is OR4 and R4 is alkyl substituted with 18F. 2. A method of imaging cardiac innervation comprising the steps of: administering an effective amount of the compound of claim 1 or a salt thereof to a patient;detecting radiation emitted by said compound; andforming an image therefrom. 3. The compound of claim 1, wherein the compound is a salt. 4. The compound of claim 1, wherein the compound is a salt of a compound selected from the group consisting of: 5. A composition for imaging cardiac innervation comprising the compound of claim 4, and optionally one or more excipients. 6. A method of imaging cardiac innervation comprising the steps of: administering an effective amount of the compound of claim 4 to a patient;detecting radiation emitted by said compound; andforming an image therefrom. 7. The compound of claim 1, wherein the compound is a salt of the compound: 8. The compound of claim 7, wherein the salt has the structure N-[3-bromo-4(3-[18F]fluoropropoxy)-benzyl]-guanidine hydrochloride. 9. A composition for imaging cardiac innervation comprising the compound of claim 7, and optionally one or more excipients. 10. A method of imaging cardiac innervation comprising the steps of: administering an effective amount of the compound of claim 7 to a patient;detecting radiation emitted by said compound; andforming an image therefrom. 11. A composition for imaging cardiac innervation comprising the compound of claim 1, and optionally one or more excipients. 12. A compound of the structure: or a salt thereof, wherein n is 1;A is absent;R2 is hydrogen or OR4, wherein R4 is H or alkyl;X, W, R and R3 are hydrogen;R1 is NHC(═NH)NH2;Y is H, F, Cl, or Br; andZ is OR4, wherein R4 is alkyl substituted with 18F. 13. A compound of the structure: or a salt thereof,wherein n is 0 or 1;A is absent;R2, when present, is hydrogen or OR4, wherein R4 is H or alkyl;X, W, R and R3 are hydrogen;R1 is NHC(═NH)NH2;Z is H, F, Cl, or Br; andY is OR4, wherein R4 is alkyl substituted with 18F. 14. A compound of the structure: or a salt thereof, wherein n is 0 or 1;R is NR4C(═NR5)NHR6;R1 is selected from the group consisting of H and alkyl (C1-C4);when present, R2 is H or OR4 R3 is H;R4, R5, and R6 are independently selected from the group consisting of H and alkyl (C1-C8), wherein one or more R4-R6 may be substituted with an imaging moiety;A is absent;W and X are hydrogen; andY and Z are independently selected from the group consisting of H, OR4, F, Cl, Br, and I,wherein Y or Z is OR4 and R4 is alkyl substituted with 18F. 15. The compound of claim 14, wherein the compound has the structure: or a salt thereof. 16. A method of imaging cardiac innervation comprising the steps of: administering an effective amount of the compound of claim 12 or a salt thereof to a patient;detecting radiation emitted by said compound; andforming an image therefrom. 17. A method of imaging cardiac innervation comprising the steps of: administering an effective amount of the compound of claim 13 or a salt thereof to a patient;detecting radiation emitted by said compound; andforming an image therefrom. 18. A method of imaging cardiac innervation comprising the steps of: administering an effective amount of the compound of claim 15 or a salt thereof to a patient;detecting radiation emitted by said compound; andforming an image therefrom. 19. A method of imaging cardiac innervation comprising the steps of: administering an effective amount of the compound of claim 14 or a salt thereof to a patient;detecting radiation emitted by said compound; andforming an image therefrom. 20. The compound of claim 13, wherein n is 0. 21. The compound of claim 14, wherein n is 0. 22. The compound of claim 13, wherein n is 1. 23. The compound of claim 14, wherein n is 1.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (36)
Peterson Steven F. (West Linn OR), Ampule filling device.
Hubbard Vance M. (Bedford) Brunson Welton K. (Bedford) Saied V. C. (Wichita Falls TX), Apparatus and method for raising a skin wheal and anesthetizing skin.
Purohit, Ajay; Benites, Pedro; Cheesman, Edward H.; Cesati, Richard R.; Looby, Richard J.; Radeke, Heike S., Compositions, methods, and systems for the synthesis and use of imaging agents.
Purohit, Ajay; Benites, Pedro; Cheesman, Edward H.; Lazewatsky, Joel; Lee, L. Veronica; Cesati, Richard R.; Looby, Richard J.; Radeke, Heike S., Compositions, methods, and systems for the synthesis and use of imaging agents.
Winchell Harry S ; Klein Joseph Y,ILX ; Simhon Elliot D,ILX ; Cyjon Rosa L,ILX ; Klein Ofer,ILX ; Zaklad Haim,ILX, Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy.
Purohit, Ajay; Harris, Thomas D.; Radeke, Heike S.; Robinson, Simon P.; Yu, Ming; Casebier, David S.; Azure, Michael T., Ligands for imaging cardiac innervation.
Lilley Stephen J. (Sawston GBX) Taylor Hugh F. (Sawston GBX) Theobald David R. (Huntingdon GBX) Carlson Craig J. (Andover MA) Rosen David I. (Arlington MA) Johnson Thomas R. (Milford NH), Medical injection system and method, gas spring thereof and launching device using gas spring.
McKinnon ; Jr. Charles N. (Laguna Niguel CA) Peterson Steven F. (West Linn OR) Smith Paul E. (Tualatin OR) Nakagawa Takaaki (Tigard OR) Bartholomew Victor L. (Tigard OR), Needleless hypodermic injection device.
Peterson Steven F. (West Linn OR) McKinnon ; Jr. Charles N. (Laguna Niguel CA) Smith Paul E. (Tualatin OR) Nakagawa Takaaki (Tigard OR) Bartholomew Victor L. (Tigard OR), Needleless hypodermic injection methods and device.
DeGrado William Frank ; Mousa Shaker Ahmed ; Sworin Michael ; Barrett John Andrew ; Edwards Scott David ; Harris Thomas David ; Rajopadhye Milind ; Liu Shuang, Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.